And Japan? [BE/BA News]

posted by ElMaestro  – Denmark, 2019-12-04 15:43 (1546 d 19:30 ago) – Posting: # 20923
Views: 5,308

Wow,

❝ A: The guideline focuses on BCS-based biowaiver principles to be applied for bioequivalence purposes provided they are supported by a sound scientific rationale. The provision in the guideline that accommodates exceptions to existing regulations that do not permit BCS-based biowaivers for generic product applications, at this time, does not disqualify implementation of these harmonized technical requirements to demonstrate BCS based biowaivers for other product applications unless explicitly stated.


I tried to read that answer 10 times now and I am none the wiser. Do they mean "The guideline will deal with BCS-based biowaivers, but it is acknowledged that some countries might not accept those." ??
:-)

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,912 posts in 4,806 threads, 1,637 registered users;
22 visitors (0 registered, 22 guests [including 7 identified bots]).
Forum time: 11:14 CET (Europe/Vienna)

Exploratory analysis: The art of finding a Rembrandt
in a Jackson Pollock.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5